← FDA DRUG APPROVALS

FDA ANDA · ANDA077628

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE

Sponsor: STRIDES PHARMA

APPLICATION
ANDA077628
TYPE
ANDA
ORIGINAL APPROVAL
2006-08-14
LATEST ACTION
2015-02-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter

Products

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDEOver-the-counter
IBUPROFEN 200MG, PSEUDOEPHEDRINE HYDROCHLORIDE 30MG · TABLET · ORAL

Approval history

2015-02-04Labeling · Supplement 7AP
2009-09-04Labeling · Supplement 4AP
2006-08-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →